DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Gamble D, Fairley R, Harvey R. et al.
Screening for valve disease in patients with hyperprolactinaemia disorders prescribed cabergoline: a service evaluation and literature review. Therap Adv.
Drug Safety 2017;
8: 215-229
We do not assume any responsibility for the contents of the web pages of other providers.